Peter A. Jones
Impact in
- Cancer Research top 0.02%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 0.01%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
- Histone Deacetylase Inhibitors Research
Papers in
-
- Epigenetics and DNA Methylation 206
- Cancer-related gene regulation 84
- RNA modifications and cancer 65
- Genomics and Chromatin Dynamics 55
-
- Cancer Genomics and Diagnostics 27
- Co-authors
- Stephen B. Baylin (17 shared papers)Gangning Liang (84 shared papers)Shirley M. Taylor (10 shared papers)Daiya Takai (5 shared papers)Gerda Egger (13 shared papers)Christine B. Yoo (16 shared papers)Daniel D. De Carvalho (11 shared papers)Ana M. Aparicio (2 shared papers)
- Journals
- Molecular and Cellular Biology (24 papers)Cancer Research (17 papers)Proceedings of the National Academy of Sciences (16 papers)Nucleic Acids Research (15 papers)Cell (11 papers)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Peter A. Jones
346 papers receiving 60.2k citations
Peter A. Jones's Hit Papers
Peers
Comparison fields: 5 of 193
- Cancer Research 9.5k
- Molecular Biology 44.9k
- Genetics 8.1k
- Oncology 7.1k
- Hematology 2.4k
Countries citing papers authored by Peter A. Jones
This map shows the geographic impact of Peter A. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Jones more than expected).
Fields of papers citing papers by Peter A. Jones
This network shows the impact of papers produced by Peter A. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Jones. The network helps show where Peter A. Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter A. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 351 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The fundamental role of epigenetic events in cancer Hit paper breakdown → | 2002 | 4414 |
| 2 | Functions of DNA methylation: islands, start sites, gene bodies and beyond Hit paper breakdown → | 2012 | 4349 |
| 3 | The Epigenomics of Cancer Hit paper breakdown → | 2007 | 3468 |
| 4 | Epigenetics in human disease and prospects for epigenetic therapy Hit paper breakdown → | 2004 | 2409 |
| 5 | A decade of exploring the cancer epigenome — biological and translational implications Hit paper breakdown → | 2011 | 2074 |
| 6 | The Role of DNA Methylation in Mammalian Epigenetics Hit paper breakdown → | 2001 | 1566 |
| 7 | Cellular differentiation, cytidine analogs and DNA methylation Hit paper breakdown → | 1980 | 1500 |
| 8 | Comprehensive analysis of CpG islands in human chromosomes 21 and 22 Hit paper breakdown → | 2002 | 1110 |
| 9 | Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Hit paper breakdown → | 2006 | 1042 |
| 10 | Epigenetic therapy of cancer: past, present and future Hit paper breakdown → | 2006 | 1018 |
| 11 | DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts Hit paper breakdown → | 2015 | 1009 |
| 12 | Multiple new phenotypes induced in and 3T3 cells treated with 5-azacytidine Hit paper breakdown → | 1979 | 938 |
| 13 | Epigenetic Determinants of Cancer Hit paper breakdown → | 2016 | 884 |
| 14 | Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer Hit paper breakdown → | 2014 | 868 |
| 15 | Targeting the cancer epigenome for therapy Hit paper breakdown → | 2016 | 812 |
| 16 | Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples Hit paper breakdown → | 1991 | 731 |
| 17 | Increased cell division as a cause of human cancer. Hit paper breakdown → | 1990 | 720 |
| 18 | The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors Hit paper breakdown → | 1999 | 687 |
| 19 | Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer Hit paper breakdown → | 1994 | 630 |
| 20 | Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Hit paper breakdown → | 1995 | 619 |
About Peter A. Jones
Peter A. Jones is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Surgery, having authored 351 papers that have together received 61.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (206 papers), Cancer-related gene regulation (84 papers), RNA modifications and cancer (65 papers), Genomics and Chromatin Dynamics (55 papers), Bladder and Urothelial Cancer Treatments (29 papers), Cancer Genomics and Diagnostics (27 papers), Genetic Syndromes and Imprinting (25 papers) and Cancer-related Molecular Pathways (22 papers). The work is most often cited by research in Cancer Research (9.5k citations), Molecular Biology (44.9k citations), Genetics (8.1k citations), Oncology (7.1k citations) and Hematology (2.4k citations). Peter A. Jones has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Stephen B. Baylin, Gangning Liang, Shirley M. Taylor, Daiya Takai, Gerda Egger, Christine B. Yoo, Daniel D. De Carvalho, Ana M. Aparicio, Keith D. Robertson and Felicidad A. Gonzales. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, Proceedings of the National Academy of Sciences, Nucleic Acids Research and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.